Ad is loading...
MENU
RARE
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Ultragenyx Pharmaceutical (RARE) Ownership - Who owns Ultragenyx Pharmaceutical?
Industry: @Biotechnology
Profile
Industry
Biotechnology
Address
60 Leveroni Court
Phone
+1 415 483-8800
Employees
1276
Web
https://www.ultragenyx.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
4.13B
P/E Ratio
N/A
Total Cash
763.82M
Projected Growth
N/A
Total Debt
37.46M
Revenue
481.3M
Risk (Beta)
0.11
Dividend Yield
N/A
Total Cash/Share
8.27
Total Debt/Equity
N/A
Revenue/Share
6.01 USD as % of share price
Fundamentals
RARE
Capitalization
4.13B
P/E Ratio
N/A
Risk (Beta)
0.11
Dividend Yield
N/A
Total Cash
764M
Total Cash/Share
8.27
Total Debt
37.5M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
6.01%
Revenue
481M
ROE
N/A
Book Value
432M
P/B Ratio
11.92
Cash Flow
N/A
Earnings
-7.21
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
92K
Current Ratio
3.54
Current Revenue Per Employee
115224.14
Dividends Per Share - Security
N/A
EBITDA
-486.94M
Float
N/A
Float - Current
N/A
Gross Income Margin
85.53
Revenue To Assets
-39.94
Shares Held By Institutions
9.69B
Shares Outstanding - Current
92.3M
Total Liabilities
1.19B
Total Volume MTD
N/A
Value
-1
Gain YTD
-6.420
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a developer of therapeutics for rare diseases
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Biotechnology
Address
60 Leveroni Court
Phone
+1 415 483-8800
Employees
1276
Web
https://www.ultragenyx.com